| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 09/25/2002 | EP1242449A1 Modified adenovirus fibre and uses |
| 09/25/2002 | EP1242116A2 Herpes simplex virus-1 glycoprotein c mutants for treating unwanted hyperproliferative cell growth |
| 09/25/2002 | CN1370831A Purificaltion process of sea fish lymphocysis virus |
| 09/24/2002 | US6455686 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 09/24/2002 | US6455314 Recombinant fiber protein having a trimerization domain and which interacts with adenoviral penton base; for gene transfer methods |
| 09/24/2002 | US6455299 Methods of use of viral vectors to deliver antigen to dendritic cells |
| 09/24/2002 | US6455298 Animal cells and processes for the replication of influenza viruses |
| 09/24/2002 | US6455265 Preparing candidate immunogenic agents based on an envelope protein of a pathogenic strain, then selecting a modified polypeptide which induces an immune response against the immunodomnant region of the protein but not the host |
| 09/24/2002 | US6455253 Methods and compositions for polypeptide engineering |
| 09/24/2002 | US6455247 Introducing library of randomized nucleic acids linked to secretion signal into cells, expressing nucleic acids to form peptides, and screening second cells which are co-cultured with first cells for altered phenotypes |
| 09/24/2002 | US6455245 For immunoassay detection |
| 09/24/2002 | US6455045 Immunogenic compounds with in particular an anti-cytokine effect, preparation process, pharmaceutical compositions and kits containing them |
| 09/24/2002 | US6455039 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (mif) gene selected from dirofilaria immitis mif gene and onchocerca volvulus mif gene |
| 09/24/2002 | US6455038 Administering reovirus for ras-mediated proliferative disorder, tumors |
| 09/19/2002 | WO2002072852A2 Leporipox-based vector vaccines |
| 09/19/2002 | WO2002072851A2 Lentiviral packaging constructs |
| 09/19/2002 | WO2002072836A2 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells |
| 09/19/2002 | WO2002072835A1 Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immune against flavivirus and other infectious agents |
| 09/19/2002 | WO2002072814A2 Engineered baculoviruses and their use |
| 09/19/2002 | WO2002072803A2 Subgenomic replicons of the flavivirus dengue |
| 09/19/2002 | WO2002072802A2 Live attenuated strains of prrs virus |
| 09/19/2002 | WO2002072776A2 Cell culture system for synthesis of infectious hepatitis c virus |
| 09/19/2002 | WO2002072754A2 Mva expressing modified hiv envelope, gag, and pol genes |
| 09/19/2002 | WO2002072140A2 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro |
| 09/19/2002 | WO2002072139A1 Avian vaccine effective against infectious bursal disease virus |
| 09/19/2002 | WO2002071843A1 Recombinant adeno-assocaited virus-mediated gene transfer via retroductal infusion of virions |
| 09/19/2002 | WO2002010379A3 Modified cea and uses thereof |
| 09/19/2002 | WO2002002765A3 Chimeric promoters for controlling expression in smooth muscle cells |
| 09/19/2002 | WO2001092299A9 Adenovirus particles with mutagenized fiber proteins |
| 09/19/2002 | WO2001083514A3 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof |
| 09/19/2002 | US20020132337 Processes for preparation of marek's disease virus using continuous avian cell lines |
| 09/19/2002 | US20020132336 Replication-defective recombinant AAV virions |
| 09/19/2002 | US20020131981 Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife |
| 09/19/2002 | US20020131956 Adeno-associated virus vectors encoding factor VIII and methods of using the same |
| 09/19/2002 | DE10111433A1 Replikationskompetente molekulare Klone von porcinem endogenem Retrovirus der Klasse A und Klasse B,abgeleitet von Schweine- und humanen Zellen Replication-competent molecular clones of porcine endogenous retrovirus class A and class B derived from porcine and human cells |
| 09/19/2002 | CA2454959A1 Mva expressing modified hiv envelope, gag, and pol genes |
| 09/19/2002 | CA2441454A1 Recombinant adeno-associated virus-mediated gene transfer via retroductal infusion of virions |
| 09/19/2002 | CA2440433A1 Cell culture system for synthesis of infectious hepatitis c virus |
| 09/19/2002 | CA2439254A1 Life attenuated strains of prrs virus |
| 09/19/2002 | CA2439188A1 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro |
| 09/19/2002 | CA2438385A1 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells |
| 09/19/2002 | CA2408214A1 Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immunize against flavivirus and other infectious agents |
| 09/18/2002 | EP1241254A1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 09/18/2002 | EP1241177A1 Recombinant infectious laryngotracheitis virus vaccine |
| 09/18/2002 | EP1240310A2 Method of inactivating microorganisms |
| 09/18/2002 | EP1240189A2 Hepatitis virus sentinel virus i (svi) |
| 09/18/2002 | EP1240186A2 Improvements in or relating to immune responses to hiv |
| 09/18/2002 | CN1370237A Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of non-essential gene |
| 09/17/2002 | US6451597 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins |
| 09/17/2002 | US6451596 Helper adenovirus vectors |
| 09/17/2002 | US6451595 Murine leukemia virus with pol, env, and gag coding regions deleted; gene therapy; gene expression and engineering |
| 09/17/2002 | US6451592 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 09/17/2002 | US6451579 Regulated expression of recombinant proteins using RNA viruses |
| 09/17/2002 | US6451323 Recombinant newcastle disease virus RNA expression systems and vaccines |
| 09/17/2002 | US6451322 Retrovirus like particles made non infectious by a plurality of mutations |
| 09/17/2002 | US6451321 Bird and poultry vaccine; side effect reduction of lesions |
| 09/17/2002 | US6451319 Deletion or insertion in dna sequence; vaccines, gene therapy |
| 09/17/2002 | US6451304 Method for retrovirus vector production by separated gag and pol expression |
| 09/17/2002 | US6451256 Recombinant viruses in frozen or liquid form, in which infectious viruses are preserved in an aqueous solution. the recombinant virus suspension comprises an aqueous sucrose solution at a concentration for gene therapy. |
| 09/15/2002 | CA2373454A1 Recombinant infectious laryngotracheitis virus vaccine |
| 09/13/2002 | CA2374027A1 Cloning, expression, sequencing, and functional enhancement of monoclonal scfv antibody against venezuelan equine encephalitis virus(vee) |
| 09/12/2002 | WO2002070720A1 Cloning vectors and method for molecular cloning |
| 09/12/2002 | WO2002070673A1 Concentration and lysis of adenovirus-infected cells in a single unit operations |
| 09/12/2002 | WO2002070651A2 Viral reporter particles |
| 09/12/2002 | WO2002070565A2 High-affinity antagonists of elr-cxc chemokines |
| 09/12/2002 | WO2001083529A3 Immunoadhesin for the prevention of rhinovirus infection |
| 09/12/2002 | WO2001081569A3 Heparanase ii, a human heparanase paralog |
| 09/12/2002 | WO2001004266A9 A lung cancer associated retrovirus, gene delivery vector and methods of use thereof |
| 09/12/2002 | US20020127721 Polypeptide for use in the treatment of cancer or genetic disorder |
| 09/12/2002 | US20020127697 Gene delivery system and methods of use |
| 09/12/2002 | US20020127595 Endostatin; for use as a contraceptive and in cancer treatment |
| 09/12/2002 | US20020127582 Generating adenovirus-associated vector; obtain cells, transform with expression vector, propagate, recover transformed cells, propagate and recover vectors |
| 09/12/2002 | US20020127564 Monitoring modulators of phenotypic expression in mammalian cells; obtain cell, transform, screen transformed cells for preferential phenotype |
| 09/12/2002 | US20020127246 Use of herpes vectors for tumor therapy |
| 09/12/2002 | US20020127207 Compositions and methods for reducing the amount of salmonella in livestock |
| 09/12/2002 | CA2440044A1 Cloning vectors and method for molecular cloning |
| 09/12/2002 | CA2439620A1 Viral reporter particles |
| 09/11/2002 | EP1239036A1 Polynucleotides, polypeptides, remedies for cancer and vaccines |
| 09/11/2002 | EP1238092A2 Bovine immunodeficiency virus (biv) based vectors |
| 09/11/2002 | EP1238061A2 A new genotype of hepatitis b virus |
| 09/11/2002 | EP1238057A2 Method for producing adherent animal cells |
| 09/11/2002 | EP1237925A1 MUTANT ER$g(a) AND TEST SYSTEMS FOR TRANSACTIVATION |
| 09/11/2002 | EP0797445B1 Use of bioassimilable aqueous boron compounds for the control of subviral pathogenic agents |
| 09/11/2002 | CN1369011A Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 09/10/2002 | US6448390 Mutant protein allows for decreased shedding of the surface protein by suppressing precursor cleavage, while maintaining mutant envelope protein incorporation into a virion |
| 09/10/2002 | US6448083 Contacting a mammalian cell with filamentous phage particles presenting a ligand on their surfaces, wherein a vector within the phage encodes a gene product under control of a promoter |
| 09/10/2002 | US6448074 Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cells |
| 09/10/2002 | US6448000 Viral growth and cellular genes that function as tumor suppressors. thus, the present invention provides nucleic acids related to and methods of reducing or preventing viral infection or cancer. the invention also provides methods of |
| 09/10/2002 | US6447994 A nucleic acid having a first nucleotide sequence encoding an infectious hepatitis c virus, a second nucleotide sequence encoding a ribozyme, and an inducible promoter operably linked to the first and second nucleotide sequences, |
| 09/10/2002 | US6447993 Protecting cats from infection by a broad range of fiv strains using a multi-subtype fiv vaccine. multi-subtype fiv vaccines comprising either cell free whole virus or cell lines infected with viruses and vaccinating cats |
| 09/06/2002 | WO2002068927A2 Using viruses to detect or purify proteins |
| 09/06/2002 | WO2002068670A1 A method for transfer of dna segments |
| 09/06/2002 | WO2002068654A2 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/06/2002 | WO2002068632A2 Methods to identify mutant cells with altered sialic acid |
| 09/06/2002 | WO2002068627A2 Vector constucts |
| 09/06/2002 | WO2002067983A1 Novel vaccine |
| 09/06/2002 | WO2002067861A2 Oncolytic adenoviral vectors |
| 09/06/2002 | WO2002000687A3 Antimicrobial peptides and methods of use thereof |
| 09/06/2002 | WO2001073093A3 Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| 09/06/2002 | WO2001018199A9 Chimaeric plant viruses with mucin peptides |